Skip to article
Astra

Critical Care

Bacterial Sepsis

Bacterial sepsis requires immediate recognition of infection-associated organ dysfunction, parallel microbiologic evaluation and resuscitation, prompt empiric antibiotics when illness is critical, source-directed control, and repeated reassessment to narrow therapy and identify noninfectious mimics.

Clinical question: How should physicians recognize, evaluate, and initially manage adults with suspected bacterial sepsis while minimizing unnecessary antimicrobial exposure?

Recognition

Identify infection-associated organ dysfunction, not infection alone

Use bedside trajectory and organ dysfunction to determine urgency.

Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Septic shock is a high-acuity subset of sepsis, but neither sepsis nor septic shock has a diagnostic gold standard. JAMAAssessment of Clinical Criteria for SepsisBMJSepsis in adults - Symptoms, diagnosis and treatment

Suspected bacterial infection must be interpreted alongside evolving physiologic impairment and alternative explanations for organ dysfunction. Conventional clinical criteria and biomarkers have important limitations for confirming infection or predicting deterioration; therefore, serial examination and repeated reassessment are essential. JAMAAssessment of Clinical Criteria for SepsisScienceDirectChallenges in early detection and prognostication of sepsis

Patients with septic shock, rapid clinical deterioration, or a high initial illness-severity score warrant immediate escalation. In one acute-care framework, NEWS2 of 7 or greater identifies high risk of severe illness or death from sepsis, although NEWS2 is not a U.S.-specific diagnostic definition and must be interpreted clinically. BMJSepsis in adults - Symptoms, diagnosis and treatmentnice org ukSuspected sepsis in people aged 16 or over

Operational triage for suspected bacterial sepsis based on supplied acute-care guidance. BMJUpdate in sepsis guidelines: what is really new?BMJSepsis in adults - Symptoms, diagnosis and treatmentnice org ukSuspected sepsis in people aged 16 or over
Clinical stateImmediate prioritiesMonitoring emphasis
Septic shock or rapidly deteriorating suspected sepsisObtain cultures and source-directed specimens promptly; begin intravenous broad-spectrum antibiotics after cultures if feasible; assess lactate, circulation, oxygen need, and urine output. BMJSepsis in adults - Symptoms, diagnosis and treatmentFrequent reassessment of clinical trajectory, hemodynamics, urine output, laboratory data, and response to resuscitation. BMJSepsis in adults - Symptoms, diagnosis and treatment
Suspected infection with organ dysfunction but without immediate shockEvaluate for infectious source and organ dysfunction; obtain microbiologic testing and institute treatment according to illness severity and likelihood of bacterial infection. BMJUpdate in sepsis guidelines: what is really new?BMJSepsis in adults - Symptoms, diagnosis and treatmentRepeat clinical assessment because deterioration can be rapid and scores do not replace judgment. ScienceDirectChallenges in early detection and prognostication of sepsisnice org ukSuspected sepsis in people aged 16 or over
Possible infection without clear organ dysfunctionAssess competing diagnoses and likelihood of bacterial infection before exposing the patient to unnecessary antibiotics. fdaFDA Executive Summarydailymed nlm nihThese highlights do not include all the information needed to use CEFIXIME safely and effectively. See full prescribing information for CEFIXIME. CEFIXIME for oral suspension, 100 mg/5 mLCEFIXIME for oral suspension, 200 mg/5 mLCEFIXIME capsules, 400 mgFor oral administration Initial U.S. Approval: 1986Reassess if new organ dysfunction, circulatory insufficiency, or clinical decline develops. BMJSepsis in adults - Symptoms, diagnosis and treatment

Diagnostic Workup

Perform microbiologic evaluation and perfusion assessment in parallel with treatment

Testing should identify a source and guide de-escalation without delaying emergency care.

For critically ill adults with suspected sepsis, obtain two sets of blood cultures, measure serum lactate, and assess hourly urine output. Obtain additional specimens and imaging based on the suspected source. Blood cultures should precede antibiotics when this can be done promptly; antimicrobial delivery should not be delayed in a critically ill patient. BMJSepsis in adults - Symptoms, diagnosis and treatment

The practical diagnostic objective is not merely to label sepsis but to establish whether infection is present, identify its source and pathogen when possible, characterize organ dysfunction, and detect a need for urgent source control or critical-care support. Traditional diagnostics may have low yield and can be slow, which contributes to empiric treatment in severe presentations. fdaFDA Executive SummaryNatureClinical validation of an AI-based blood testing device for ...

Procalcitonin is an adjunct rather than a replacement for clinical assessment. FDA material reports that, among patients with severe sepsis or septic shock, a decline of 80% or less from diagnosis to day 4 was associated with higher 28-day all-cause mortality than a decline greater than 80%; this is prognostic information and does not establish a validated treatment-duration rule. fdaFDA Executive Summary

High-yield initial evaluation in critically ill suspected sepsis. BMJSepsis in adults - Symptoms, diagnosis and treatmentNatureClinical validation of an AI-based blood testing device for ...
Test or assessmentDecision valueImportant limitation
Two sets of blood culturesMay identify bloodstream pathogen and enable targeted therapy. BMJSepsis in adults - Symptoms, diagnosis and treatmentCultures should not materially delay antimicrobial therapy in critical illness. BMJSepsis in adults - Symptoms, diagnosis and treatment
Source-directed cultures or specimensSupport localization and de-escalation when an infectious focus is suspected. BMJUpdate in sepsis guidelines: what is really new?Negative results do not independently exclude infection. fdaFDA Executive SummaryNatureClinical validation of an AI-based blood testing device for ...
Serum lactateAssesses physiologic severity and should be included in initial critical-illness evaluation. BMJSepsis in adults - Symptoms, diagnosis and treatmentNo supplied source supports use of a single lactate threshold as a standalone diagnostic rule.
Hourly urine outputProvides ongoing assessment of organ perfusion and organ dysfunction. BMJSepsis in adults - Symptoms, diagnosis and treatmentMust be integrated with the full hemodynamic and renal clinical context. BMJSepsis in adults - Symptoms, diagnosis and treatment
Procalcitonin trendMay contribute prognostic information in severe sepsis or septic shock. fdaFDA Executive SummarySupplied evidence does not support it as a definitive diagnostic test or independent antibiotic stop rule. fdaFDA Executive SummaryNatureClinical validation of an AI-based blood testing device for ...

Emergency Management

Start empiric therapy promptly in critical illness and reassess continuously

Initial management is simultaneous resuscitation, infection treatment, and diagnostic clarification.

For patients with critical illness at presentation, including septic shock or rapidly deteriorating sepsis, acute-care guidance recommends obtaining cultures, measuring lactate, monitoring urine output, administering intravenous broad-spectrum antibiotics after cultures when bacterial infection is evident, giving intravenous fluids for circulatory insufficiency, and providing oxygen when needed. BMJSepsis in adults - Symptoms, diagnosis and treatment

Empiric antibiotics should cover likely pathogens, with consideration of bacterial and, when risk factors justify it, viral or fungal causes. Older Surviving Sepsis Campaign guidance summarized in the supplied literature recommended two agents from different classes for septic shock when directed at the most likely pathogens, while noting that bacteremia, neutropenic sepsis, and sepsis without shock do not routinely require combination therapy. BMJUpdate in sepsis guidelines: what is really new?

The evidence base for exact antimicrobial strategies and durations in sepsis remains limited. Regimen selection, dose, infusion strategy, renal adjustment, and treatment duration should therefore be driven by the suspected source, local antibiogram, prior microbiology, allergy history, organ function, host immune status, source control, culture results, and clinical response; the supplied sources do not support a universal empiric regimen or dose. Oxford AcademicAntimicrobial Treatment Duration in Sepsis and Serious ...

Antimicrobial decision points in bacterial sepsis. BMJUpdate in sepsis guidelines: what is really new?Oxford AcademicAntimicrobial Treatment Duration in Sepsis and Serious ...
Time pointDecisionEvidence-informed action
Initial recognition of critical illnessNeed for empiric treatmentAdminister intravenous broad-spectrum antibiotics promptly after cultures when feasible in critically ill patients with evidence of bacterial infection. BMJSepsis in adults - Symptoms, diagnosis and treatment
Before regimen selectionSpectrum and combination therapyMatch coverage to likely source, pathogens, and host risk; supplied guidance supports combination empiric therapy principally for septic shock, not routine combination therapy for sepsis without shock. BMJUpdate in sepsis guidelines: what is really new?
After microbiology and clinical reassessmentDe-escalationNarrow therapy when pathogen and susceptibility data are known or when clinical evolution supports a more focused regimen. BMJUpdate in sepsis guidelines: what is really new?
During ongoing treatmentDurationIndividualize to source, source control, microbiology, and response; optimal antimicrobial treatment strategies in sepsis remain insufficiently defined. Oxford AcademicAntimicrobial Treatment Duration in Sepsis and Serious ...

Antimicrobial stewardship after the first dose

Initial broad coverage is a time-sensitive risk-management decision, not a commitment to a fixed regimen. Review the working diagnosis, culture results, susceptibility data, source control status, organ dysfunction, and response daily. De-escalate or discontinue antibacterial therapy when evidence no longer supports bacterial infection, and narrow therapy when a pathogen and susceptibilities are established. BMJUpdate in sepsis guidelines: what is really new?dailymed nlm nihThese highlights do not include all the information needed to use CEFIXIME safely and effectively. See full prescribing information for CEFIXIME. CEFIXIME for oral suspension, 100 mg/5 mLCEFIXIME for oral suspension, 200 mg/5 mLCEFIXIME capsules, 400 mgFor oral administration Initial U.S. Approval: 1986

Do not extrapolate drug-specific renal-adjustment information across antimicrobial classes. For example, cefprozil labeling recommends 50% of the standard dose at creatinine clearance 0 to 29 mL/min and administration after hemodialysis, whereas cefixime labeling also requires renal adjustment but does not provide a universal cephalosporin rule. dailymed nlm nihPRESCRIBING INFORMATION CEFPROZIL TABLETS Rx only Cefprozil Tablets 250 mg and 500 mg To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefprozil and other antibacterial drugs, cefprozil should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.dailymed nlm nihThese highlights do not include all the information needed to use CEFIXIME safely and effectively. See full prescribing information for CEFIXIME. CEFIXIME for oral suspension, 100 mg/5 mLCEFIXIME for oral suspension, 200 mg/5 mLCEFIXIME capsules, 400 mgFor oral administration Initial U.S. Approval: 1986

Ongoing Care

Find the source and escalate when physiology fails to improve

Clinical improvement depends on more than antimicrobial selection.

The initial evaluation should repeatedly seek an actionable infectious focus. Persistent instability, recurrent fever, worsening organ dysfunction, or failure to improve despite apparently appropriate empiric coverage should prompt reassessment of the diagnosis, adequacy of source control, antimicrobial activity, drug exposure, and noninfectious mimics. The supplied literature emphasizes early identification, tailored antibiotics, laboratory evaluation, and coordinated resuscitative care. BMJUpdate in sepsis guidelines: what is really new?BMJSepsis in adults - Symptoms, diagnosis and treatment

Frequent monitoring is required because sepsis severity is dynamic. Ongoing bedside assessment, urine output, lactate measurement, oxygen requirement, hemodynamics, and microbiologic data should inform escalation or de-escalation. BMJSepsis in adults - Symptoms, diagnosis and treatmentScienceDirectChallenges in early detection and prognostication of sepsis

Reassessment triggers in suspected bacterial sepsis. BMJUpdate in sepsis guidelines: what is really new?BMJSepsis in adults - Symptoms, diagnosis and treatmentScienceDirectChallenges in early detection and prognostication of sepsis
TriggerReassessPotential next action
Persistent or worsening organ dysfunctionSource, microbiology, antimicrobial adequacy, resuscitation response, and alternative diagnoses. BMJUpdate in sepsis guidelines: what is really new?ScienceDirectChallenges in early detection and prognostication of sepsisEscalate monitoring and specialty support; pursue source-directed diagnostic evaluation. BMJSepsis in adults - Symptoms, diagnosis and treatmentScienceDirectChallenges in early detection and prognostication of sepsis
Culture identification and susceptibility resultsWhether broad empiric coverage remains necessary. BMJUpdate in sepsis guidelines: what is really new?Narrow to targeted therapy when appropriate. BMJUpdate in sepsis guidelines: what is really new?
Clinical improvement without microbiologic confirmationProbability of bacterial infection and need for continued antibacterial exposure. fdaFDA Executive Summarydailymed nlm nihThese highlights do not include all the information needed to use CEFIXIME safely and effectively. See full prescribing information for CEFIXIME. CEFIXIME for oral suspension, 100 mg/5 mLCEFIXIME for oral suspension, 200 mg/5 mLCEFIXIME capsules, 400 mgFor oral administration Initial U.S. Approval: 1986Consider de-escalation or discontinuation when bacterial infection is no longer strongly suspected. dailymed nlm nihThese highlights do not include all the information needed to use CEFIXIME safely and effectively. See full prescribing information for CEFIXIME. CEFIXIME for oral suspension, 100 mg/5 mLCEFIXIME for oral suspension, 200 mg/5 mLCEFIXIME capsules, 400 mgFor oral administration Initial U.S. Approval: 1986
Diarrhea during or after antibioticsPossibility of C. difficile infection. dailymed nlm nihThese highlights do not include all the information needed to use CEFIXIME safely and effectively. See full prescribing information for CEFIXIME. CEFIXIME for oral suspension, 100 mg/5 mLCEFIXIME for oral suspension, 200 mg/5 mLCEFIXIME capsules, 400 mgFor oral administration Initial U.S. Approval: 1986Discontinue nonessential antibacterials and manage confirmed C. difficile infection as clinically indicated. dailymed nlm nihThese highlights do not include all the information needed to use CEFIXIME safely and effectively. See full prescribing information for CEFIXIME. CEFIXIME for oral suspension, 100 mg/5 mLCEFIXIME for oral suspension, 200 mg/5 mLCEFIXIME capsules, 400 mgFor oral administration Initial U.S. Approval: 1986

Common questions

Does a low procalcitonin exclude bacterial sepsis?

No. The supplied evidence indicates that no single biomarker can determine infection presence, pathogen type, and severity. Procalcitonin trends may add prognostic information in severe sepsis or septic shock but should not override clinical assessment. fdaFDA Executive SummaryNatureClinical validation of an AI-based blood testing device for ...

Should blood cultures delay antibiotics in suspected septic shock?

No. Obtain blood cultures promptly before antibiotics when feasible, but critically ill patients should receive prompt intravenous broad-spectrum therapy rather than waiting for delayed diagnostic testing. BMJSepsis in adults - Symptoms, diagnosis and treatment

Is empiric combination antibiotic therapy required for all sepsis?

No. Supplied guidance supports empiric combination therapy principally for septic shock; bacteremia, neutropenic sepsis, and sepsis without shock were not considered to require routine combination therapy. BMJUpdate in sepsis guidelines: what is really new?

How should empiric antibiotics be managed after cultures return?

Review source, organism, susceptibility, source control, and clinical response, then narrow therapy when possible. The supplied evidence does not support a universal antibiotic duration for sepsis. BMJUpdate in sepsis guidelines: what is really new?Oxford AcademicAntimicrobial Treatment Duration in Sepsis and Serious ...

References

  1. FDA Executive Summarywww.fda.gov · www.fda.gov
  2. PRESCRIBING INFORMATION CEFPROZIL TABLETS Rx only Cefprozil Tablets 250 mg and 500 mg To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefprozil and other antibacterial drugs, cefprozil should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.dailymed.nlm.nih.gov · dailymed.nlm.nih.gov
  3. See full prescribing information for complete boxed warningdailymed.nlm.nih.gov · dailymed.nlm.nih.gov
  4. highlights of prescribing informationdailymed.nlm.nih.gov · dailymed.nlm.nih.gov
  5. These highlights do not include all the information needed to use CEFIXIME safely and effectively. See full prescribing information for CEFIXIME. CEFIXIME for oral suspension, 100 mg/5 mLCEFIXIME for oral suspension, 200 mg/5 mLCEFIXIME capsules, 400 mgFor oral administration Initial U.S. Approval: 1986dailymed.nlm.nih.gov · dailymed.nlm.nih.gov
  6. Approval Label_220934s003lbl - accessdata.fda.govwww.accessdata.fda.gov · www.accessdata.fda.gov
  7. - IIER - accessdata.fda.govwww.accessdata.fda.gov · www.accessdata.fda.gov
  8. Sepsis Prediction Model vs SIRS, qSOFA, and SOFAjamanetwork.com · jamanetwork.com
  9. Assessment of Clinical Criteria for Sepsisjamanetwork.com · jamanetwork.com
  10. Update in sepsis guidelines: what is really new?tsaco.bmj.com · tsaco.bmj.com
  11. Sepsis in adults - Symptoms, diagnosis and treatmentbestpractice.bmj.com · bestpractice.bmj.com
  12. What's new in the management of neonatal early-onset ...fn.bmj.com · fn.bmj.com
  13. Clinical validation of an AI-based blood testing device for ...www.nature.com · www.nature.com
  14. Compliance with SEP-1 guidelines is associated ...www.sciencedirect.com · www.sciencedirect.com
  15. Implementation of an adult code sepsis protocol and its impact on SEP-1 core measure perfect score attainment in the EDwww.sciencedirect.com · www.sciencedirect.com
  16. Antimicrobial Treatment Duration in Sepsis and Serious ...academic.oup.com · academic.oup.com
  17. The JAID/JSC guidelines for management of infectious ...www.sciencedirect.com · www.sciencedirect.com
  18. Challenges in early detection and prognostication of sepsiswww.sciencedirect.com · www.sciencedirect.com
  19. Why IDSA Did Not Endorse the Surviving Sepsis Campaign ...academic.oup.com · academic.oup.com
  20. CDC's Hospital Sepsis Program Core Elements are ...academic.oup.com · academic.oup.com
  21. Sepsis National Hospital Inpatient Quality Measure (SEP-1)academic.oup.com · academic.oup.com
  22. Identification and management of maternal sepsis during and following pregnancy (Green-top Guideline No. 64) | RCOGwww.rcog.org.uk · www.rcog.org.uk
  23. Suspected sepsiswww.nice.org.uk · www.nice.org.uk
  24. Suspected sepsis in people aged 16 or overwww.nice.org.uk · www.nice.org.uk